Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Pharmaceutical Market Access in Emerging Markets
The definition of Market Access was first reported by the World Trade Organization as “to open markets for trade and improve transparency, reciprocity, and non-discrimination in international trade”. Pharmaceutical Market Access is different and it could be defined as achieving the optimal price for a product or service and/or the maximum reimbursement for the approved target population with no restrictions on funding for the medical technology. By the way, Market Access is not only the market authorization, but it also includes overlapping activities like pricing, health technology assessment, formulary, and reimbursement. Market Access is one of the most important activities for pharma...
Pharmaceutical Market Access in Developed Markets
Market access is the process by which a pharmaceutical company gets its product available on the market after having obtained a marketing authorization from a regulatory agency and by which the product becomes available for all patients for whom it is indicated as per its marketing authorization. It covers a group of activities intended to provide access to the appropriate medicine for the appropriate group of patients at the appropriate price (in most countries). Market Access may also be seen as activities that support the management of potential barriers, such as non-optimal price and reimbursement levels, the restriction of the scope of prescribing for the drug or complicated prescription writing or funding procedures. Since there are cultural differences among countries, any Market Access strategy needs to be culturally sensitive. Pharmaceutical Market Access in emerging markets has been extensively discussed in our previous book, published in 2016. The present book focuses on developed markets with the goal of helping students, academics, industry personnel, government workers, and decision makers understand the environment in developed markets.
Leadership Action and Intervention in Health, Business, Education, and Technology
In today's rapidly evolving landscape of healthcare, social sciences, and technology, the complexity of interconnected challenges often leaves scholars feeling adrift in a sea of disparate information. As disciplines become increasingly intertwined, navigating the nexus of these fields poses a significant obstacle for academic scholars seeking comprehensive understanding and innovative solutions. A cohesive resource that effectively bridges these divides is necessary to progress and hampers efforts to address pressing issues such as healthcare disparities, ethical dilemmas in technology, and social justice concerns. Leadership Action and Intervention in Health, Business, Education, and Technology is a meticulously crafted guide thorugh the murky waters of interdisciplinary study, offering a comprehensive exploration of the critical intersections between healthcare, social sciences, and technology. This book empowers academic scholars to transcend disciplinary boundaries, foster collaboration, and drive meaningful change in an increasingly interconnected world.
Digital Technology in the Management and Prevention of Diabetes
Diabetes is a chronic disease characterized by hyperglycemia resulting from defects in insulin production, its efficacy, or both. In recent years, the growth of the diabetes endemic has been an escalating global health concern, impacting all ages and societies. Diabetes causes a range of complications such as heart disease, stroke, kidney failure, and vision loss, impacting an individual's quality of life, as well as increasing both morbidity and mortality. It is due to this that constant monitoring and lifestyle modifications are needed to ensure individuals have adequate management of the disease. Digital technology has been pivotal in revolutionizing patient care in the 21st century, directly impacting diabetes management and prevention by providing new risk assessments, diagnosis, treatment and telemedicine. The integration of health informatics in diabetes care offers seamless tracking, monitoring, and personalization of the care process, enhancing experiences for both caregivers and patients. Yet, the potential of this fast-evolving field stands largely untapped, necessitating further exploration to harness its robustness in diabetes control and prevention.
